Put companies on watchlist
Semperit AG Holding
ISIN: AT0000785555
WKN: 870378
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Semperit AG Holding · ISIN: AT0000785555 · EQS - adhoc news (52 News)
Country: Austria · Primary market: Austria · EQS NID: 1441759
13 September 2022 07:00PM

Semperit AG Holding identifies probable impairment loss in Medical Sector in the order of approximately EUR 50 million


EQS-Ad-hoc: Semperit AG Holding / Key word(s): Miscellaneous
Semperit AG Holding identifies probable impairment loss in Medical Sector in the order of approximately EUR 50 million

13-Sep-2022 / 19:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosed inside information / Ad hoc release

Semperit identifies probable impairment loss in Medical Sector in the order of approximately EUR 50 million

 

Vienna, Austria, 13 September 2022 – Against the backdrop of the market dynamics for examination and protective gloves, the Executive Board of Semperit AG Holding reviewed the estimates and assumptions relevant to the valuation with regard to the Medical Sector (Sempermed segment). As a result, a probable impairment loss in the order of approximately EUR 50 million as of 30 September 2022 was identified for the segment assets of Sempermed.

The exact amount of the impairment loss will be included in the third quarter business development figures and will be disclosed at the latest with the publication of the Q1-3 2022 results on 16 November 2022.



For queries, please contact:

Monika Riedel                
Director Group Brand Management,     
Corporate Spokesperson       
+43 676 8715 8620  
monika.riedel@semperitgroup.com

Judit Helenyi
Director Investor Relations
+43 676 8715 8310
judit.helenyi@semperitgroup.com


www.semperitgroup.com

www.linkedin.com/company/semperit-ag


 


13-Sep-2022 CET/CEST News transmitted by EQS Group AG. www.eqs.com


Language: English
Company: Semperit AG Holding
Am Belvedere 10
1100 Wien
Austria
Phone: +43 1 79 777-310
Fax: +43 1 79 777-602
E-mail: judit.helenyi@semperitgroup.com
Internet: www.semperitgroup.com
ISIN: AT0000785555
Listed: Vienna Stock Exchange (Official Market)
EQS News ID: 1441759

 
End of Announcement EQS News Service

1441759  13-Sep-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1441759&application_name=news&site_id=boersengefluester_html
Visual performance / price development - Semperit AG Holding
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.